Article: Anika Therapeutics Broadens Global Distribution for ELEVESS(TM) in Four New Countries.

Agreement Expands Anika's Global Market for Breakthrough Injectable Dermal Filler with Distributors in Mexico, Chile, Peru, and South Korea

BEDFORD, Mass. -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed exclusive agreements with three new dermatology focused distributors to market ELEVESS in Mexico, Chile, Peru and South Korea. ELEVESS is an injectable filler that reduces the appearance of lines and wrinkles on the face, and was the first HA-based dermal filler approved by the U.S. Food and Drug Administration to incorporate the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!